Navigation Links
Mainz University Medical Center agrees partnership with Yale University

The University Medical Center at Johannes Gutenberg University Mainz, Germany and the renowned School of Medicine at Yale University, USA have agreed upon a future collaboration. This strategic partnership promises to provide an innovative stimulus for the Research Unit Translational Neurosciences at the Mainz University Medical Center. The resulting regular exchange will benefit both basic research and the training of young researchers.

"Our aim is to arrive at a better understanding of brain development and functioning by working closely with the neuroscientists at Yale University. This should provide us with the necessary insight to develop new medications and diagnostic tests for treating neurological and psychiatric illnesses such as stroke, depression, or schizophrenia," says the Chief Scientific Officer of the Mainz University Medical Center, Professor Dr. Dr. Reinhard Urban. Urban is convinced that the work being done in the Research Unit Translational Neurosciences (FTN) can be significantly advanced through access to the existing expertise at Yale University. The Yale Kavli Institute for Neuroscience, like the Research Unit Translational Neurosciences in Mainz, employs a multidisciplinary research strategy covering fields ranging from molecular genetics to behavioral research. The aim of this joint project is to explore at both locations the development, cellular organization, and function of the nervous system in controlling cognition, memory, language, and thought.

"The transfer of knowledge resulting from the intensive exchange of established scientists, doctoral candidates, and postdoctoral researchers from Yale and Mainz will increase the opportunities for making cutting-edge discoveries in basic research. These research findings can then be incorporated into new diagnostic and therapeutic procedures in accordance with the 'from bench to bedside' principle," explains Professor Dr. Robert Nitsch, spokesman of the Research Unit Translational Neurosciences and Director of the Institute of Microscopic Anatomy and Neurobiology. "The collaboration with Yale means that the world's leading neuroscientists are now pooling their resources," says Nitsch, welcoming the positive effect that the partnership with the elite US university located in New Haven, Connecticut will have for the Mainz research center.

The Mainz University Medical Center now hopes to further extend the collaboration, initiated by Dr. Robert Nitsch, to other research units. "We are confident that our Research Units for Immunology and for Vascular Prevention as well as our BiomaTICS Research Group will also soon be working hand-in-hand with the Yale School of Medicine," emphasizes Professor Dr. Dr. Reinhard Urban, Chief Scientific Officer of the University Medical Center. Initial projects are already in the planning stages.


Contact: Oliver Kreft
Johannes Gutenberg Universitaet Mainz

Related biology news :

1. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
2. Mainz University coordinates new EU project on the origins of human settlement
3. Scientists from Bangalore and Mainz develop new methods for cooling of ions
4. University of Houston study shows BP oil spill hurt marshes, but recovery possible
5. University of Alberta led research may have discovered how memories are encoded in our brains
6. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
7. Marshall University study may lead to new treatments for prostate cancer
8. University leads £6 million EU project to tackle obesity
9. A University of Tennessee professors hypothesis may be game changer for evolutionary theory
10. Life expectancy may affect when you get married, divorced, have kids: Queens University study
11. University of Toronto biologists predict extinction for organisms with poor quality genes
Post Your Comments:
(Date:11/11/2015)... MINNETONKA, Minn. , Nov. 11, 2015   MedNet ... the entire spectrum of clinical research, is pleased to announce ... Partnerships in Clinical Trials (PCT) event, to be held ... will be able to view live demonstrations of ... platform, and learn how iMedNet has been able ...
(Date:11/9/2015)... 09, 2015 ... the "Global Law Enforcement Biometrics Market ... --> ) has announced the ... Biometrics Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
(Date:11/25/2015)... The Global Genomics Industry ... and in-depth study on the current state of ... ) , The report provides ... classifications, applications and industry chain structure. The Genomics ... including development trends, competitive landscape analysis, and key ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT ... provide a corporate overview. th Annual Oppenheimer Healthcare ... ET/10:00 a.m. PT . Jim Mazzola , vice president ... --> th Annual Oppenheimer Healthcare Conference in ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide ... Carolina , today announced that the company has set a ... a 391% quarter on quarter growth posted for Q3 of 2014 ... and Mexico , with the establishment of ... December 2015. --> United Kingdom and ...
Breaking Biology Technology: